Muscle Abnormalities in Children With XLH (MDmuscleXLH)
Muscle Weakness, XLH
About this trial
This is an interventional other trial for Muscle Weakness focused on measuring XLH rickets, IMAT, intraMAT, muscle weakness, MRI
Eligibility Criteria
Inclusion Criteria common criteria to the 2 groups:
- Age: between 5 and 17 years.
- Sex: male or female.
- Informed consent, signed by both parents or holder of parental autority after being informated of the study.
- Affiliation to a social security schema or having the right to.
Inclusion criteria for XLH Patients :
- Patient suffer of X-linked hypophosphatemia rickets.
- Severity of clinical and radiological damage (pain, muscle weakness and severe bone deformities).
- Growth in progress (bone age less than 15 years).
- Child under conventional treatment: patient responding to conventional treatment or
- under treatment with Burosumab (patient in treatment failure under treatment conventional).
incluion criteria for helthy volunteers :
- Healthy voluntary subjects, not suffering from XLH.
- Matching by age (+/- 6 months) and sex.
Exclusion Criteria common to the 2 groups :
- Not being able to stay still during the MRI examination (approximately 45 min).
- Growth completed.
- History of lower limb surgery.
- Contraindications to MRI
- Holders of parental authority under AME.
- Holders of parental authority under tutorship / curatorship.
Exclusion criteria for Healthy volunteers :
- Patients with endocrine, contracted or muscular pathology.
- Patient receives a long-term treatment.
- Patients with a high athletic level.
- BMI-IOTF <20 or> 27.8
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
patients with X-linked hypophosphatemic
healthy volunteers
Patient group composed of 10 patients aged between 5 to 17 years old, female or male, with X-linked hypophosphatemic (XLH) rickets, severity of clinical and radiological damage (pain, muscle weakness and severe bone deformities) and ongoing growth (lesser bone age than 15 years old), child under conventional treatment
control group composed of 20 helthy volunteers aged between 5 to 17 years old, female or male, without any endocrine pathology, not suffering from XLH, matching by age (+/- 6 months) and sex